SNDX

SNDX Other Income/Expenses (Net)

-$26.59MTTM · USD

Period ending:

SNDX FY Other Income/Expenses (Net)USD
SNDX FY Other Income/Expenses (Net)2011-12-31: -$3.47M2012-12-31: -$1.23M2013-12-31: -$5.60M2014-12-31: $1.50M2015-12-31: -$3.61M2016-12-31: -$706.00K2017-12-31: $1.15M2018-12-31: $1.92M2019-12-31: $1.49M2020-12-31: -$1.74M2021-12-31: -$1.29M2022-12-31: $2.42M2023-12-31: $20.59M2024-12-31: $20.91M2025-12-31: -$12.34M$20.91M-$12.34M
2011-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

SNDX other income/expenses (net) history

Net other income and expenses outside core operations. The available annual fiscal periods series contains 15 observations from Dec 31, 2011 to Dec 31, 2025.

Syndax Pharmaceuticals Inc Other Income/Expenses (Net) — Annual fiscal periods (USD)
Period endingOther Income/Expenses (Net) (USD)
-12,338,000
20,914,000
20,594,000
2,419,000
-1,294,000
-1,735,000
1,492,000
1,915,000
1,152,000
-706,000
-3,606,000
1,504,000
-5,600,000
-1,231,000
-3,466,000

Compare other income/expenses (net)

All SNDX financial metrics · SNDX stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.